Resources

Laboratory Improves Propofol Testing Following New Research Data Laboratory Improves Propofol Testing Following New Research Data

05-Jul-2013

New data from researchers at USDTL shows that propofol use can be detected in urine samples for as long as 28 days following low-dose anesthesia.

Test Helps Identify Newborns Exposed to Fentanyl Abuse Test Helps Identify Newborns Exposed to Fentanyl Abuse

30-Sep-2019

Over the last few decades, United States Drug Testing Laboratories, Inc. (USDTL), has been quietly making a huge impact on the lives of some of the most vulnerable Neonatal Intensive Care Unit (NICU) patients, newborns exposed to substances of abuse during gestation. Today USDTL announced that they are the first laboratory in the world to commercially offer newborn fentanyl testing in both meconium and umbilical cord tissue specimens.

Laboratory Markets Innovative Test to Detect PEth in Newborn Blood Specimens Laboratory Markets Innovative Test to Detect PEth in Newborn Blood Specimens

5-Feb-2018

United States Drug Testing Laboratories, Inc. (USDTL), a pioneer in newborn forensic toxicology, alcohol biomarkers, and substances of abuse testing has announced a breakthrough in measuring Phosphatidylethanol (PEth) in newborn blood.